| AO | Adverse outcome |
| AOP | Adverse outcome pathway |
| BPA | Bisphenol-A |
| BPF | Bisphenol-F |
| BPS | Bisphenol-S |
| CdCl2 | Cadmium chloride |
| CFDA-AM | Carboxyfluorescein diacetate acetoxymethyl ester |
| DDE | Dichlorodiphenyldichloroethylene |
| DEHP | Di(2-ethylhexyl) phthalate |
| EDCs | Endocrine-disrupting chemicals |
| EndoC-βH1 | Human pancreatic β cell line EndoC-βH1 |
| GSIS | Glucose-stimulated insulin secretion |
| KEs | Key events |
| MDCs | Metabolism-disrupting chemicals |
| MIN6 | Mouse insulinoma 6 |
| NRU | Neutral red uptake |
| OECD | Organization for Economic Cooperation and Development |
| PFOS | Perfluorooctanesulfonic acid |
| RZ | Resazurin |